![Drug manufacturing laboratory equipment](https://www.nortonrosefulbright.com/-/media/images/nrf/thought-leadership/canada/publications/life-sciences-healthcare-lab-equipment.jpg?w=265&revision=355955d3-b814-40be-80c7-63b3ad62cb43&revision=5248910870347387904&hash=1F3BEDB56F2489EB29C4E2FCBDED3656)
Publication
Health Canada identifies lithium-ion batteries, infant bath seats, and water beads as hazards of concern
Health Canada has recently identified three new classes of products that pose a hazard of concern.
Insurance companies in Asia Pacific face complex regulatory issues that can impact their ability to operate across multiple jurisdictions.
Regulators differ by jurisdiction when it comes to permitting branches of foreign insurance companies to operate, with some allowing only locally incorporated companies. Furthermore, restrictions may be imposed on foreign direct investment and controller regimes – shareholders and management – making it essential for companies to determine if approval from the regulator is required upon proposed change of control (direct or indirect). Companies also need to be familiar with the nature of the regulatory capital regime, whether there is group supervision, a mandatory policy holder protection regime, and whether outsourcing is subject to regulatory oversight.
To help our clients navigate these areas, we have produced ‘Insurance regulation in Asia Pacific’ as part of our NRF Institute, which provides an overview and practical checklist of ten common regulatory issues for insurance companies operating, or seeking to operate, in 19 jurisdictions across Asia Pacific.
Publication
Health Canada has recently identified three new classes of products that pose a hazard of concern.
Publication
An employer’s ability to ask for a sick note when an employee is absent from work due to illness is becoming increasingly curtailed across Canada.
Publication
Since 2022, the Government of Canada has introduced three waves of amendments to the Competition Act (Act), making substantive changes to Canada’s competition laws, with the most recent amendments receiving royal assent on June 20, 2024.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2023